Skip to main content
SpringerLink
Log in

Lung Transplantation for Pulmonary Arterial Hypertension

  • Chapter
  • First Online:
Essentials in Lung Transplantation

  • 788 Accesses

Abstract

Pulmonary arterial hypertension constitutes a group of disorders with a common haemodynamic definition. There are a number of medical therapies available for these diseases, but a proportion of patients will not respond adequately and will require lung transplantation as the final therapy.Lung transplantation in this disease is extremely complex both in the timing or referral and listing for transplantation and in the peri-operative management. With careful decision making excellent long term results can be achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yusen RD, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35(10):1170–84.

    Article  PubMed  Google Scholar 

  2. Andersen KH, et al. Pulmonary hypertension as a risk factor of mortality after lung transplantation. Clin Transpl. 2016;30(4):357–64.

    Article  Google Scholar 

  3. Hoeper MM, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42–50.

    Article  PubMed  Google Scholar 

  4. Galiè N, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2015;37(1):67–119.

    Article  PubMed  Google Scholar 

  5. Barst RJ, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334(5):296–301.

    Article  CAS  Google Scholar 

  6. Rubin LJ, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med. 1990;112(7):485–91.

    Article  CAS  PubMed  Google Scholar 

  7. Sitbon O, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111(23):3105–11.

    Article  CAS  Google Scholar 

  8. Reitz BA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306(10):557–64.

    Article  CAS  PubMed  Google Scholar 

  9. Kramer MR, et al. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol. 1994;73(7):494–500.

    Article  CAS  PubMed  Google Scholar 

  10. Pielsticker EJ, Martinez FJ, Rubenfire M. Lung and heart-lung transplant practice patterns in pulmonary hypertension centers. J Heart Lung Transplant. 2001;20(12):1297–304.

    Article  CAS  PubMed  Google Scholar 

  11. Olland A, et al. Should we perform bilateral-lung or heart-lung transplantation for patients with pulmonary hypertension? Interact Cardiovasc Thorac Surg. 2013;17(1):166–70.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Schaffer JM, et al. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era. Circulation. 2013;127(25):2503–13.

    Article  PubMed  Google Scholar 

  13. Levvey BJ, et al. Donation after circulatory determination of death lung transplantation for pulmonary arterial hypertension: passing the toughest test. Am J Transplant. 2015;15(12):3208–14.

    Article  CAS  PubMed  Google Scholar 

  14. Weill D, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1–15.

    Article  PubMed  Google Scholar 

  15. Kylhammar D, et al. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. 2017.

    Google Scholar 

  16. Humbert M, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010;36(3):549–55.

    Article  CAS  PubMed  Google Scholar 

  17. Benza RL, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122(2):164–72.

    Article  PubMed  Google Scholar 

  18. Lantuejoul S, et al. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol. 2006;30(7):850–7.

    Article  PubMed  Google Scholar 

  19. Humbert M, et al. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1681–5.

    Article  CAS  PubMed  Google Scholar 

  20. Montani D, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87(4):220–33.

    Article  Google Scholar 

  21. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. 1958;2(5099):755–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Choong CK, et al. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience. J Thorac Cardiovasc Surg. 2005;129(3):661–9.

    Article  PubMed  Google Scholar 

  23. Waddell TK, et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21(7):731–7.

    Article  PubMed  Google Scholar 

  24. Galie N, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger’s syndrome. Drugs. 2008;68(8):1049–66.

    Article  CAS  PubMed  Google Scholar 

  25. Avouac J, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol. 2010;37(11):2290–8.

    Article  PubMed  Google Scholar 

  26. Hachulla E, et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study. Rheumatology (Oxford). 2009;48(3):304–8.

    Article  Google Scholar 

  27. Bernstein EJ, et al. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study. Arthritis Rheumatol. 2015;67(5):1314–22.

    Article  PubMed  Google Scholar 

  28. Launay D, et al. Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group. Presse Med. 2014;43(10 Pt 2):e345–63.

    Article  PubMed  Google Scholar 

  29. Christie JD, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report—2008. J Heart Lung Transplant. 2008;27(9):957–69.

    Article  PubMed  Google Scholar 

  30. Diamond JM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013;187(5):527–34.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Halldorsson AO, et al. Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation. Ann Thorac Surg. 1998;66(3):877–84; discussion 884-5.

    Article  CAS  PubMed  Google Scholar 

  32. Tudorache I, et al. Lung transplantation for severe pulmonary hypertension—awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling. Transplantation. 2015;99(2):451–8.

    Article  CAS  PubMed  Google Scholar 

  33. Fuehner T, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med. 2012;185(7):763–8.

    Article  PubMed  Google Scholar 

  34. Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia. 2015;70(1):56–70.

    Article  CAS  PubMed  Google Scholar 

  35. Ius F, et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;144(6):1510–6.

    Article  PubMed  Google Scholar 

  36. Akagi S, et al. High frequency of acute adverse cardiovascular events after lung transplantation in patients with pulmonary arterial hypertension receiving preoperative long-term intravenous prostacyclin. Int Heart J. 2017;58(4):557–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, The Alfred Hospital, Melbourne, VIC, Australia

    Helen Whitford

  2. Monash University, Clayton, VIC, Australia

    Helen Whitford

Authors
  1. Helen Whitford
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen Whitford .

Editor information

Editors and Affiliations

  1. The Lung Transplant Unit, Department of Thoracic Medicine, St Vincent’s Hospital, Sydney, NSW, Australia

    Allan R. Glanville

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Whitford, H. (2019). Lung Transplantation for Pulmonary Arterial Hypertension. In: Glanville, A. (eds) Essentials in Lung Transplantation . Springer, Cham. https://doi.org/10.1007/978-3-319-90933-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90933-2_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90932-5

  • Online ISBN: 978-3-319-90933-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation